Physician profile
Edwin Rao
NPI 1912909763
$1,282.17
in general payments reported to CMS, 2019-2025
16 companies · $410 in 2025
The $410 reported for 2025 was more than what a typical Critical Care Medicine (Internal Medicine) provider received nationally (typical 2025 total: $189).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $263 · 2024: $609 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,282.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $329.23 | 2023-2025 | Ofev |
| Insmed, INC. | $211.76 | 2023-2024 | Arikayce |
| Ani Pharmaceuticals, INC. | $138.78 | 2024-2025 | Purified Cortrophin Gel |
| Regeneron Healthcare Solutions, INC. | $108.68 | 2024-2025 | Dupixent |
| Mylan Specialty L.P. | $92.68 | 2024 | Yupelri |
| La Jolla Pharmaceutical Company | $57.84 | 2023-2025 | Xerava |
| Ucb, INC. | $54.57 | 2025 | Bimzelx |
| Melinta Therapeutics, LLC | $53.40 | 2023-2024 | Rezzayo, Kimyrsa, Vabomere |
| Baxter Healthcare | $46.81 | 2023-2024 | Hillrom - Vest System Model 105 Home Care |
| Glaxosmithkline, LLC. | $37.44 | 2025 | Trelegy Ellipta, Nucala |
| Genzyme Corporation | $32.13 | 2024-2025 | |
| Janssen Biotech, INC. | $30.97 | 2024 | Tremfya |
| Viatris Specialty LLC | $27.02 | 2025 | Yupelri |
| United Therapeutics Corporation | $23.86 | 2025 | Tyvaso |
| Actelion Pharmaceuticals US, INC. | $21.98 | 2024 | Opsumit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.02 | 2024 | Tavneos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edwin Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.